2022
Cost‐Effectiveness of Surgical Weight‐Loss Interventions for Patients With Knee Osteoarthritis and Class III Obesity
Kostic A, Leifer V, Gong Y, Robinson M, Collins J, Neogi T, Messier S, Hunter D, Selzer F, Suter L, Katz J, Losina E. Cost‐Effectiveness of Surgical Weight‐Loss Interventions for Patients With Knee Osteoarthritis and Class III Obesity. Arthritis Care & Research 2022, 75: 491-500. PMID: 35657632, PMCID: PMC9827536, DOI: 10.1002/acr.24967.Peer-Reviewed Original ResearchMeSH KeywordsCost-Benefit AnalysisGastrectomyGastric BypassHumansLaparoscopyObesityObesity, MorbidOsteoarthritis, KneeWeight LossConceptsIncremental cost-effectiveness ratioLaparoscopic sleeve gastrectomyClass III obesityUsual careLifetime costsHealth care sector perspectiveProbabilistic sensitivity analysesCost-effectiveness ratioQuality-adjusted life expectancyOsteoarthritis Policy ModelSurgical weight loss interventionsLong-term clinical benefitKnee OA patientsKnee osteoarthritis patientsSensitivity analysisSustainable weight lossWeight loss interventionWorse knee painKnee replacement outcomesPolicy modelSector perspectiveTotal knee replacement outcomesGastric bypassKnee painOpioid use
2013
Placing a Price on Medical Device Innovation: The Example of Total Knee Arthroplasty
Suter LG, Paltiel AD, Rome BN, Solomon DH, Thornhill TS, Abrams SK, Katz JN, Losina E. Placing a Price on Medical Device Innovation: The Example of Total Knee Arthroplasty. PLOS ONE 2013, 8: e62709. PMID: 23671626, PMCID: PMC3646021, DOI: 10.1371/journal.pone.0062709.Peer-Reviewed Original Research
2011
Cost-effectiveness of Adding Magnetic Resonance Imaging to Rheumatoid Arthritis Management
Suter LG, Fraenkel L, Braithwaite RS. Cost-effectiveness of Adding Magnetic Resonance Imaging to Rheumatoid Arthritis Management. JAMA Internal Medicine 2011, 171: 657-667. PMID: 21482840, PMCID: PMC4047037, DOI: 10.1001/archinternmed.2011.115.Peer-Reviewed Original ResearchConceptsIncremental cost-effectiveness ratioMagnetic resonance imagingStandard risk stratificationCost-effectiveness ratioLifetime incremental cost-effectiveness ratioEarly rheumatoid arthritisRisk stratificationRheumatoid arthritisAggressive treatmentResonance imagingBaseline radiographic erosionsRA-related costsEarly RA patientsMonths of diseaseRheumatoid arthritis managementStandard treatment protocolHigh-risk individualsProbabilistic sensitivity analysesDecision analysis modelRadiographic erosionsRA patientsDisease courseArthritis managementMRI specificityClinical markers